NCT01953952View on ClinicalTrials.gov

Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Stage III Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the OropharynxTongue Cancer
Interventions
PROCEDURE

therapeutic conventional surgery

Undergo transoral eHNS

RADIATION

intensity-modulated radiation therapy

Undergo IMRT

DRUG

cisplatin

Given IV

PROCEDURE

quality-of-life assessment

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

94305

Stanford University Hospitals and Clinics, Stanford

Sponsors

Collaborators (1)

NRG Oncology
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

NRG Oncology

OTHER

lead

Radiation Therapy Oncology Group

NETWORK

NCT01953952 - Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter